Keele Research Repository
Explore the Repository
Tools
Chapman, SR, Fitzpatrick, RW and Aladul, MI (2016) Did Cost Inhibit the Uptake of More potent Statins? Pharmacoepidemiology and Drug Safety, 25 (S2). pp. 3-23. ISSN 1099-1557

There is a more recent version of this item available.
Official URL: http://dx.doi.org/10.1002/pds.4019
Item Type: | Article |
---|---|
Additional Information: | Abstract of paper presented at Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 “Ethics, Economics and the Future of Medicines – A Population Perspective” This is the peer reviewed version of the following abstract: Anon, 2016. Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 “Ethics, Economics and the Future of Medicines - A Population Perspective.” Pharmacoepidemiol Drug Saf, 25, pp.3–23, which has been published in final form at http://dx.doi.org/10.1002/pds.4019 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving. |
Uncontrolled Keywords: | statins, simvastatin, atorvastatin, generics, prescribing |
Subjects: | R Medicine > R Medicine (General) |
Divisions: | Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine |
Depositing User: | Symplectic |
Date Deposited: | 18 May 2016 14:12 |
Last Modified: | 11 Jun 2018 13:50 |
URI: | https://eprints.keele.ac.uk/id/eprint/1737 |
Available Versions of this Item
- Did Cost Inhibit the Uptake of More potent Statins? (deposited 18 May 2016 14:12) [Currently Displayed]
Actions (login required)
Altmetric